Loading provider…
Loading provider…
Clinical Cardiac Electrophysiology Physician in Anchorage, AK
NPI: 1336395599Primary Practice Location
Alaska Heart Institute
3841 Piper St, Anchorage, AK
Primary Employer
Alaska Heart Institute
alaskaheart.com
HQ Phone
Get M.D. Mark's Phone Numberphone_androidMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardAK State Medical License
VA State Medical License
WA State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 374 | 416 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 126 | 134 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 123 | 123 |
| 4 | 33208Insertion of new or replacement of permanent pacemaker including upper and lower chamber electrodes | 58 | 58 |
| 5 | 99223Initial hospital inpatient care, typically 70 minutes per day | 55 | 56 |
A wearable cardioverter defibrillator with a low false alarm rate.
Authors: Sean Beinart, Tariq Salam, Marye Gleva, Yongmei Cha, Ulrika Birgersdotter-Green, Kelley Branch, Thomas Crawford, Jeanne Poole, Ghiath Mikdadi
Journal: J Cardiovasc Electrophysiol
Publication Date: 2022-02-28
Safety and feasibility of cardiac electrophysiology procedures in ambulatory surgery centers.
Authors: Padraig Oneill, David Kenigsberg, Jason Zagrodzky, Rhea Mahapatra, Steven Compton, Kenneth Ellenbogen, Vijendra Swarup, Andrea Natale, David Kenigsberg, Arash Aryana
Journal: Heart Rhythm
Publication Date: 2024-08-05
Lead Sponsor: Kestra Medical Technologies, Inc.
Collaborators: Regulatory and Clinical Research Institute Inc
Intervention / Treatment: DEVICE: Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system
Lead Sponsor: Kestra Medical Technologies, Inc.
Collaborators: Regulatory and Clinical Research Institute Inc
Intervention / Treatment: DEVICE: ASSURE™ Wearable Cardioverter Defibrillator (WCD)